Clinical trial Recruiting at 1 site Observational Ages 18 and up

Continuous jugular venous oxygen saturation monitoring after cardiac arrest

Official title: Feasibility and Validation of Continuous Measurement of Jugular Venous Oxygen Saturation in Comatose Patients After Cardiac Arrest

Run by University of Pittsburgh · NCT06511999 · Data updated 2026-11-12

This project will test continuous and intermittent jugular venous oxygen saturation monitoring in adults who are comatose after cardiac arrest to see if brain oxygen delivery patterns can be detected and tracked.

More Cardiac Arrest trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment25 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedSeptember 20, 2025
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJune 5, 2026
Trial IDNCT06511999 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) resuscitated from out-of-hospital or in-hospital cardiac arrest who remain comatose with motor Glasgow Coma Scale ≤4 off sedation for at least 30 minutes are ideal candidates.

Probably not a fit

Patients whose cardiac arrest was due to traumatic brain injury, intracranial bleeding, or ischemic stroke, those with unstable cervical spine fractures, extreme hemodynamic instability, moribund neurologic status, pregnancy, or incarceration are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults who achieve return of spontaneous circulation but remain comatose after cardiac arrest will undergo placement of a PediaSat oximetry catheter in the jugular vein to measure jugular venous oxygen saturation (SjO2). Some patients will have continuous SjO2 monitoring while others will have intermittent blood-sample-based measurements using the same catheter and hospital blood gas analysis. This observational protocol will record SjO2 trends alongside standard neurocritical care measures such as targeted temperature management, blood pressure, oxygenation, carbon dioxide targets, and EEG monitoring. The goal is to characterize between-patient heterogeneity in brain oxygen delivery after cardiac arrest to inform potential individualized neuroprotective treatments.

Why it matters

Potential benefit: If successful, this could help clinicians detect episodes of inadequate brain oxygen delivery earlier and tailor treatments to each patient's needs, potentially improving neurologic recovery.

How similar studies have gone: Jugular venous oximetry and other neuromonitoring techniques are used clinically, but there is limited direct evidence that SjO2-guided management improves neurological outcomes after cardiac arrest, so this approach is relatively novel in terms of demonstrated benefit.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

• Adults (\>=18 years old) resuscitated from out-of-hospital or in-hospital cardiac arrest who remain comatose (motor Glasgow coma scale \<=4) for at least 30 minutes when examined off sedation/neuromuscular blockade.

Exclusion Criteria:

* Cardiac arrest due to traumatic brain injury, intracranial bleeding, or ischemic stroke
* Cervical spine fracture
* Need for immediate prone positioning for severe hypoxemic respiratory failure
* Marked hemodynamic instability precluding priority of any neuromonitoring (multiple recurrent cardiac arrests, norepinephrine equivalents \> 1.5 mcg/kg/min)
* Moribund neurological status based upon initial clinical, radiographic and historical assessment (e.g. diffuse cerebral edema or herniation on head computed tomography)
* Pregnancy
* Prisoners

Where it's running

  • UPMC Presbyterian Hospital
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.